MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Depreciation & Amortization 2011-2026 | EW
Annual Depreciation & Amortization Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 155 M | 145 M | 140 M | 135 M | 107 M | 89.3 M | 77.4 M | 81.9 M | 71.2 M | 65.8 M | 68.6 M | 62.9 M | 53.7 M | 58 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | 53.7 M | 97.8 M |
Quarterly Depreciation & Amortization Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 36.6 M | - | - | - | 38.5 M | - | - | - | 35.2 M | - | 104 M | - | 34.7 M | - | 102 M | - | 32.4 M | - | 74.6 M | 49 M | 24.5 M | - | 65.4 M | 42.3 M | 20.6 M | - | 57.5 M | 38.3 M | 19.1 M | - | 60.7 M | 40 M | 21.1 M | - | 52.1 M | 33.9 M | 15.9 M | - | 51.3 M | 32.8 M | 16 M | - | 50.3 M | 32.3 M | 16.2 M | - | 45.8 M | 28.8 M | 14.1 M | - | 42.2 M | 27.8 M | 13.8 M | - | 43.2 M | 29.3 M | 14.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 13.8 M | 39.4 M |
Depreciation & Amortization of other stocks in the Medical devices industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
191 K | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
451 K | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
6.66 M | $ 28.6 | -1.92 % | $ 1.32 B | USA |
 |
Alphatec Holdings
ATEC
|
77.5 M | $ 12.19 | -3.02 % | $ 1.83 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
11.7 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
3.75 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bruker Corporation
BRKR
|
184 M | $ 36.62 | -4.9 % | $ 5.46 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
13.7 M | $ 8.63 | 2.92 % | $ 620 M |  Israel |
 |
Conformis
CFMS
|
4.03 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
8.1 M | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 9.51 | -0.94 % | $ 1.29 B | USA |
 |
Electromed
ELMD
|
1.04 M | $ 24.0 | -1.56 % | $ 203 M | USA |
 |
Apollo Endosurgery
APEN
|
1.21 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
487 K | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
3.69 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
17.1 M | $ 40.21 | -2.9 % | $ 1.25 B | USA |
 |
EDAP TMS S.A.
EDAP
|
2.56 M | $ 4.21 | -0.94 % | $ 157 M |  France |
 |
Avinger
AVGR
|
289 K | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
692 K | $ 3.16 | -3.07 % | $ 109 M | USA |
 |
Eargo
EAR
|
5.46 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
400 K | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
4.54 M | $ 18.48 | -0.48 % | $ 121 M | USA |
 |
Accuray Incorporated
ARAY
|
6.15 M | $ 0.49 | -2.39 % | $ 50.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
1.57 M | $ 0.82 | 1.35 % | $ 44.6 M | USA |
 |
Align Technology
ALGN
|
145 M | $ 173.34 | -1.29 % | $ 13 B | USA |
 |
Butterfly Network
BFLY
|
8.9 M | $ 3.65 | -2.93 % | $ 773 M | USA |
 |
BIOLASE
BIOL
|
2.8 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
1.43 B | $ 109.92 | -0.95 % | $ 191 B | USA |
 |
IRadimed Corporation
IRMD
|
818 K | $ 98.53 | -1.57 % | $ 1.25 B | USA |
 |
Inogen
INGN
|
20.7 M | $ 6.46 | -1.37 % | $ 172 M | USA |
 |
InMode Ltd.
INMD
|
695 K | $ 13.26 | -1.45 % | $ 857 M | Israel |
 |
BioSig Technologies
BSGM
|
188 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.37 B | $ 71.46 | -2.09 % | $ 106 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
21.1 M | $ 18.05 | 1.29 % | $ 423 M | USA |
 |
IRIDEX Corporation
IRIX
|
1.1 M | $ 1.24 | -10.14 % | $ 20 M | USA |
 |
Pulmonx Corporation
LUNG
|
1.1 M | $ 2.03 | 25.78 % | $ 79.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
45 K | $ 2.17 | -3.55 % | $ 1.32 M | USA |
 |
Medtronic PLC
MDT
|
2.86 B | $ 90.96 | -2.2 % | $ 117 B | USA |